Advanced Technology Ventures (ATV) is a bi-coastal venture capital firm that focuses on communications, infrastructure, software and services, consumer technology, biopharmaceuticals, medical devices, and cleantech.
Advanced Technology Ventures invests in seed/startup, early stage, late venture, and growth capital investments. The firm targets investments in information technology, healthcare, energy, and cleantech with a focus on software and services, internet services, internet infrastructure, medical devices, life sciences, therapeutic devices, pharmaceuticals, biopharmaceuticals, in-vitro diagnostics, and research products. Within healthcare, it seeks to invest in next-generation biologics, targeted drug delivery, immunomodulation, new mechanisms for CNS diseases, capital-efficient drug development strategies, minimally invasive therapeutics, therapy enabling technologies, and digitization. Within information technology, the firm seeks to invest in performance marketing, Software as a Service (SaaS), social media engagement, cloud computing, and dynamic data center, mobile platforms, and internet video. Within cleantech, it invests in smart grid technologies, energy storage, energy efficiency, building materials/lighting, clean energy infrastructure, water technologies, and oil and gas technologies and services. The firm seeks to invest in the United States, Canada, Europe, and Israel. The firm invests between $10 million and $15 million in its portfolio companies. It originates and leads syndicated deals and seeks Board representation on its portfolio companies. Advanced Technology Ventures was founded in 1979 and is based in Menlo Park, California with an additional office in Boston, Massachusetts.
Advanced Technology Ventures (ATV) is an American venture capital firm with more than $1.8 billion in capital under management. The firm was founded in 1979 and invests in IT, healthcare, and cleantech companies. ATV has offices in Waltham, Massachusetts and Palo Alto, California. It operates in the areas of Venture Growth, Mezzanine, Secondaries, and Leveraged buyout.
ATV's investments in IT, healthcare and cleantech companies have resulted in 30+ successful exits via IPO or acquisition.
ATV backs a variety of early-stage portfolio companies, including the following.:
- IT: Alfalight, Anagran, Apprion, CaseCentral, Cenzic, Cedexis, CombineNet, Handango, Host Analytics, HVVi Semiconductors, Liquid Engines, Nextivity, Nominum, Omneon, Packet Design, Qumu, Sanovi, Tripwire, X+1
- Cleantech: AltaRock Energy, Coskata, CaliSolar, GreatPoint Energy, Nuventix, Rive Technology, Sub-One Technology, Solar Junction, Wakonda
- Healthcare: Acceleron, Aperio, Apoptos, Ardian, ConcepTx Medical, Emphasys, EndoGastric Solutions, Five Prime, GI Dynamics, GluMetrics, Gynesonics, Helixis, Hydra BioSciences, NeuroVista, Plexxikon, PolyRemedy, Portola, Powervision, Proteolix, Second Genome, Valeritas, Zeltiq
Advanced Technology Ventures has had 58 exits as of February 2019. Advanced Technology Ventures's most notable exits include Host Analytics, Cedexis, and Five Prime Therapeutics. The majority of ATV's portfolio companies are based in North America, with a few located in Europe and Israel.
ATV focuses investment in the following areas:
- Next-generation Biologics
Advances in protein engineering addressing new target classes that have been challenging for antibody-based approaches .
- Targeted Drug Delivery
Technologies for organ, tissue or cell-line specific delivery of small molecule or biologic therapeutics, including RNAi .
Therapeutics for controlled activation or de-activation of immune system function, excluding cancer immunotherapy .
- New Mechanisms for CNS Disease
Disease-modifying approaches for major CNS disorders such as Alzheimer's and other forms of dementia, depression, epilepsy, and Parkinson's .
- Capital-Efficient Drug Development Strategies
New strategies for streamlining drug development using biomarker-based patient stratification, offshoring of selected studies, drug repositioning .
- Minimally Invasive Therapeutics
Disruptive innovations that address unmet clinical needs and which possess superior safety, efficacy and cost profiles relative to existing alternatives .
- Therapy Enabling Technologies
Novel innovations that provide significant clinical value by enabling clinicians and patients to address costly and clinically relevant inefficiencies in the delivery of care. These innovations may include diagnostics, imaging, robotics, drug delivery, and technology-enabled services .
Solutions that leverage digitization platforms and proprietary algorithms to guide therapies, enhance workflows and improve the accuracy of diagnostic efforts .
- Performance Marketing
Enabling technologies or services that provide advertisers with the ability to better target their marketing spending and measure its impact, particularly in the online and mobile markets .
- Software as a Service (SaaS)
Business applications and services that are hosted online and sold on a subscription, as-needed basis .
- Social Media Engagement
Applications that enable businesses to interact and engage with their customer via social media.
- Cloud Computing and Dynamic Data Center
Software, services, and enabling technologies to facilitate the consumption of computing resources like computing cycles, memory, and bandwidth on an as-needed basis .
- Mobile Platforms
Platforms and enabling technologies that facilitate the creation of new applications and services on mobile networks and devices.
- Internet Video
Products and services that enable the distribution, consumption, and monetization of video via the Web .
- Smart Grid Technologies
Disruptive communications and software solutions that accelerate the integration of renewables in the grid and enable reliable delivery of green power to support global infrastructure growth .
- Energy Storage
Market leading innovations in materials and control systems to accelerate vehicle electrification and integration of intermittent renewable sources in the utility grid .
- Energy Efficiency - Building Materials / Lighting
Novel energy-efficient building materials, lighting solutions and control systems that deliver superior performance while drastically reducing energy usage. Strong focus on commercial and industrial efficiency .
- Clean Energy Infrastructure
Disruptive innovations that accelerate deployment of renewables including, but not limited to, solar / wind / geothermal components that enhance energy capture and accelerate grid parity, novel materials for transmission infrastructure.
- Water Technologies
New technologies and service models for the purification, cleaning, re-use and desalination of water for the industrial, commercial and heavy industry sectors .
- Oil & Gas Technologies and Services
Improved isolation, identification and extraction technologies, and services for the oil, natural gas, coalbed methane, oil shale, and oil sands segments.
Venture Round - EndoGastric Solutions
Private Equity Round - Gynesonics
Series B - Oasys Water
Series B - Second Genome
Series B - Cedexis
Venture Round - EndoGastric Solutions
Private Equity Round - Gynesonics
Series D - Thrasos
Series E - Host Analytics
Nominum is a Redwood City, California-based company founded in 1999 by Paul Mockapetris.
Actifio is a company developing enterprise data-as-a-service.
Second Genome is a company that is developing microbiome modulators for infection, immunity and metabolic diseases.
WildTangent is a Bellevue, Washington-based company.
Oasys Water is a Boston-based company founded by Ben Jabbawy, Avi Goldberg, Rob McGinnis and Jim Matheson.
EndoGastric Solutions is a medical device company developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD).
A public company based in pleasanton, california
Hypnion was acquired by Eli Lilly and Company.
ChannelAdvisor is a Morrisville, North Carolina-based company founded in 2001.
Aquion Energy is a Lawrenceville-based electronics company.
A pharmaceutical company engaged in the discovery and development of medicines for inflammatory conditions
A biotechnology company focused on the discovery and development of protein therapeutics
Intellitactics is an enterprise software company.
Integrated wound management systems designed to increase consistency by extending wound care expertise to the point of care.
Gynesonics develops an ablatian device for uterine fibroids.
GreatPoint Energy is a Chicago-based sustainable energy company founded in 2005 by Andrew Perlman.
A biopharmaceutical company that develops therapeutics to treat cancer
Qumu is a Minneapolis-based company.
A company developing small molecule drugs treat cancer
Craig E. Dauchy
Actifio raises $100 mln from Crestline Investors, others
Cerevance Launched with New Technology, Drug Portfolio and $36M in Cash to Tackle Brain Diseases
Enterprise DaaS software provider Actifio Raises $100M | FinSMEs
Enterprise data-as-a-service firm Actifio raises $100M on $1.3B valuation - SiliconANGLE
Gynesonics closes $75m financing round
Documentaries, videos and podcasts
John Nardone, Chairman/CEO of [X+1] - Venture Capital Videos from ATV - Advanced Technology Ventures
Keys to Success - Venture Capital Videos from ATV - Advanced Technology Ventures
Leading People - Venture Capital Videos from ATV - Advanced Technology Ventures
Mike Peronto, CEO of WildTangent - Venture Capital Videos from ATV - Advanced Technology Ventures